Precision Biosensor, Inc. (KOSDAQ:335810)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,540.00
-14.00 (-0.90%)
At close: Aug 28, 2026

Precision Biosensor Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
4,2843,2911,7232,4267,5575,544
Short-Term Investments
7,2997,1362,0954,0901,09317,140
Cash & Short-Term Investments
11,58310,4273,8186,5178,65022,683
Cash Growth
231.99%173.11%-41.41%-24.66%-61.87%-5.38%
Accounts Receivable
2,9001,9981,7351,8211,6572,305
Other Receivables
579.29443.9683.29646.08332.68439.78
Receivables
3,9242,8853,1092,4671,9892,745
Inventory
8,6948,8748,9949,2349,6397,524
Prepaid Expenses
162.51158.87107.21108.06155.74212.39
Other Current Assets
512.64223.88342.33118.9336.03130.72
Total Current Assets
24,87622,56916,37118,44520,77133,295
Property, Plant & Equipment
25,01126,44530,83633,46927,80615,490
Long-Term Investments
1,5001,5001,5005,0005,0005,000
Other Intangible Assets
3,2711,8982,6763,2253,75924.16
Long-Term Deferred Tax Assets
---477.37370.25164
Other Long-Term Assets
632.54662.35656.591,171612.621,746
Total Assets
63,38153,07452,03962,47859,01055,718

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
700.8700.8545.06430.28769.13902.86
Accrued Expenses
1,1361,1461,172979.08585.07680.54
Short-Term Debt
4,1084,3835,9624,6448,113-
Current Portion of Long-Term Debt
7,5007,5006,0003,0003,000-
Current Portion of Leases
614.39691.72746.6703.94725.23104.41
Current Unearned Revenue
27.5226.09----
Other Current Liabilities
2,8723,1354,9663,5886,849463.86
Total Current Liabilities
16,95817,58319,39113,34520,0412,152
Long-Term Debt
1,5001,5004,37510,7863,0009,325
Long-Term Leases
522.12549.24579.311,1651,717222.34
Long-Term Unearned Revenue
16.0521.74----
Pension & Post-Retirement Benefits
727.49436.37579.59593.94646.15313.06
Other Long-Term Liabilities
134.79216.981,4164,560230.175,353
Total Liabilities
20,18220,30826,34130,45125,63417,365

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
10,9758,9795,8075,8075,7965,683
Additional Paid-In Capital
80,48472,29358,30157,59954,41553,224
Retained Earnings
-49,406-49,539-39,561-32,132-27,361-20,699
Comprehensive Income & Other
1,3561,0331,150753.8525.75145.8
Shareholders' Equity
43,20032,76725,69832,02733,37538,353
Total Liabilities & Equity
63,38153,07452,03962,47859,01055,718

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
14,24414,62417,66320,29916,5559,652
Net Cash (Debt)
-2,661-4,197-13,845-13,783-7,90413,032
Net Cash Growth
------43.30%
Net Cash Per Share
-179.36-332.53-1192.10-1187.80-685.771154.32
Filing Date Shares Outstanding
21.8817.9611.6111.6111.5911.37
Total Common Shares Outstanding
21.8817.9611.6111.6111.5911.37
Working Capital
7,9184,986-3,0215,099729.4631,143
Book Value Per Share
1974.711824.652212.542757.532879.323374.36
Tangible Book Value
31,83830,86923,02128,80329,61638,329
Tangible Book Value Per Share
1455.371718.961982.122479.872555.063372.23
Land
8,4559,0379,0379,0377,5422,723
Buildings
13,51213,51214,97414,9537,6857,685
Machinery
13,91813,63113,97310,70110,4127,655
Construction In Progress
76.5212.25111.352,7924,793764